FDA Drug Application (075061) for NAPROXEN by SANDOZ

Back to FDA Applications sponsored by SANDOZ

Application Number075061
Product Number001
FormTABLET, DELAYED RELEASE;ORAL
Dosage375MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNAPROXEN
Active IngredientNAPROXEN

Active IngredientCount
List of drugs with Active Ingredient NAPROXEN8


Back to FDA Applications sponsored by SANDOZ